Glenmark Introduces Vancomycin Hydrochloride Injection in the US Market
Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has recently launched Vancomycin Hydrochloride for Injection USP in the United States. Glenmark Introduces Vancomycin Hydrochloride Injection in the US Market to expand its institutional portfolio and provide a high-quality alternative to existing formulations. This antibiotic is now available in single-dose vials of 750 mg, […]
Glenmark Introduces Vancomycin Hydrochloride Injection in the US Market Read More »